SLS BIO Co (XKRX:246250) ROCE % : 3.88% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SLS BIO Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 3.88%.

SLS BIO Co ROCE % Historical Data

The historical data trend for SLS BIO Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co ROCE % Chart

SLS BIO Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

17.47

-9.33

6.07

28.07

8.97

SLS BIO Co Quarterly Data
	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial			4.05	23.25	2.30	11.93	3.88

SLS BIO Co ROCE % Calculation

SLS BIO Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1158.226	/	( ( (11752.854 - 2043.389)	+	(17837.584 - 1735.743) )	/ 2 )
	=	1158.226	/	( (9709.465	+	16101.841)	/ 2 )
	=	1158.226	/	12905.653
	=	8.97 %

SLS BIO Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	617.04	/	( ( (17837.584 - 1735.743)	+	(17567.099 - 1835.422) )	/ 2 )
	=	617.04	/	( ( 16101.841	+	15731.677 )	/ 2 )
	=	617.04	/	15916.759
	=	3.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

SLS BIO Co (XKRX:246250) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SLS BIO Co ROCE % Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SLS BIO Co (XKRX:246250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229

Website

http://www.slabs.co.kr

SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines